BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9763832)

  • 21. The management of basal cell carcinomas.
    Barry J; Oon SF; Watson R; Barnes L
    Ir Med J; 2006 Jun; 99(6):179-81. PubMed ID: 16921825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
    van der Meer GT; Willemse F; Marck KW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
    Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
    Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of skin malignancy: to what extent should we rely on clinical diagnosis?
    Brown SJ; Lawrence CM
    Br J Dermatol; 2006 Jul; 155(1):100-3. PubMed ID: 16792759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal cell carcinoma--new aspects of diagnosis and treatment.
    Wennberg AM
    Acta Derm Venereol Suppl (Stockh); 2000; 209():5-25. PubMed ID: 10884941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dermatology in private practice in France in 2000].
    Lukasiewicz E; Martel J; Roujeau JC; Flahault A
    Ann Dermatol Venereol; 2002 Nov; 129(11):1261-5. PubMed ID: 12514513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors of recurrence of basal cell carcinomas of the eyelid].
    Ducasse A; Pluot M; Gotzamanis A; Brugniart C; Leccia L; Rossi P
    J Fr Ophtalmol; 2002 May; 25(5):512-6. PubMed ID: 12048517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dermoscopy survey to assess who is using it and why it is or is not being used.
    Noor O; Nanda A; Rao BK
    Int J Dermatol; 2009 Sep; 48(9):951-2. PubMed ID: 19702978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell carcinoma and the need for regular and life-long total cutaneous examinations.
    Marghoob AA; Slade J; Kopf AW
    Compr Ther; 1994; 20(7):375-8. PubMed ID: 7924226
    [No Abstract]   [Full Text] [Related]  

  • 30. Perioperative management and the associated rate of adverse events in dermatological procedures performed by dermatologists in New Zealand.
    Chan BC; Patel DC
    Australas J Dermatol; 2009 Feb; 50(1):23-8. PubMed ID: 19178488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of skin biopsy triage decisions in 49 patients with pigmented lesions and skin neoplasms: store-and-forward teledermatology vs face-to-face dermatology.
    Shapiro M; James WD; Kessler R; Lazorik FC; Katz KA; Tam J; Nieves DS; Miller JJ
    Arch Dermatol; 2004 May; 140(5):525-8. PubMed ID: 15148095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basal cell carcinoma].
    Lacour JP
    Rev Prat; 1999 Apr; 49(8):824-8. PubMed ID: 10337193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of patch testing and methodology of dermatologists in the US: results of a cross-sectional survey.
    Warshaw EM; Nelson D
    Am J Contact Dermat; 2002 Jun; 13(2):53-8. PubMed ID: 12022120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment off-label prescribing in Dermatology].
    Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
    Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of basal cell carcinoma of the skin].
    Reymann F
    Ugeskr Laeger; 1984 Aug; 146(34):2535-8. PubMed ID: 6515862
    [No Abstract]   [Full Text] [Related]  

  • 38. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment for squamous cell carcinoma and basal cell carcinoma of skin].
    Takenouchi T
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):591-5. PubMed ID: 18468002
    [No Abstract]   [Full Text] [Related]  

  • 40. Short German guidelines: basal cell carcinoma.
    Hauschild A; Breuninger H; Kaufmann R; Kortmann RD; Schwipper V; Werner J; Reifenberger J; Dirschka T; Garbe C
    J Dtsch Dermatol Ges; 2008 May; 6 Suppl 1():S2-4. PubMed ID: 18801139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.